The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Agency for Medical Innovations sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Agency for Medical Innovations is a manufacturer of medical equipment and solutions for surgical applications. The company’s product portfolio includes pelvic floor prolapse, stress incontinence devices, morcellation equipment, infusion ports, laparoscopy devices, and other surgical devices. Its operations also include wholesale distribution of surgical and additional medical instruments, apparatus, and equipment. Its products find applications in coloproctology, urology, laparoscopy, urogynaecology, and obesity surgery. AMI is headquartered in Feldkirch, Vorarlberg, Austria.
The key metrics of Agency for Medical Innovations related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Agency for Medical Innovations is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Agency for Medical Innovations.
For a detailed understanding of the performance of Agency for Medical Innovations, buy the report here.